SDIX, LLC
SDIX, a wholly owned subsidiary of OriGene Technologies specializing in high quality, large-scale, GMP antibody production. All sites are ISO13485:2016 Certified. Products include critical immunoreagents such as Troponin I, Strep A, CRP, Apo A1, Apo B, Micro-albumin, lmmunoglobulins as well as Human Serum Calibrators. SDIX's services include antiserum development and production in a variety of species as well as large-scale monoclonal antibody production (ascites and in vitro).
Press Releases
-
Monoclonal Production
- 60,000 plus animal capacity
- Large scale (mgs to kgs)
- In Vivo and In Vitro production
- Cell line Optimization Experts
- Purification and Conjugation Services
Polyclonal Production
- Rabbits, Goats, Sheep and Chickens
- 16,000 + animal capacity
- Large scale (Liters to 100’s of Liters)
- Specialists in blending and custom formulation
- Protocol/Immunization Specialists
-
Monoclonal Production
- 60,000 plus animal capacity
- Large scale (mgs to kgs)
- In Vivo and In Vitro production
- Cell line Optimization Experts
- Purification and Conjugation Services
Polyclonal Production
- Rabbits, Goats, Sheep and Chickens
- 15,000+ animal capacity
- Large scale (Liters to 100’s of Liters)
- Specialists in blending and custom formulation
- Protocol/Immunization Specialists